Macrocyclic compound
AssigneesVernalis (R&D) Ltd, Asahi Kasei Pharma Corporation
InventorsTakahiko Ito, Misato Takashima, Masakazu Atobe, Koichiro Arai, Tomohisa Toyama, Yu Yoshii, Andrew John Potter, Daniel Paul Maddox, Stuart Ray, Nicolas Foloppe
Life of this patent
Estimating the term…
Abstract
A compound represented by the general formula (1) or a salt thereof, which has a superior IRAK-4 inhibitory activity, and is useful as active ingredients of medicaments for prophylactic treatment and/or therapeutic treatment of diseases relating to IRAK-4 inhibition.
Claims19
A compound represented by the following formula (1):
- in the formula (1),
- R1 is —H, C1-6 alkyl, halogeno-C1-6 alkyl, hydroxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, —C(O)R12, —S(O2)R12, —C(O)NR11R12, —C(O) OR12, or a 3- to 7-membered saturated ring group, R1 may be substituted with the same or different 1 to 3 substituents selected from a group G1;
- the group G1 is a group consisting of —F, hydroxy, cyano, halogeno-C1-6 alkyl, C1-4 alkoxy, phenyl, 5- to 6-membered heteroaryl, and a 3- to 7-membered saturated ring group, the phenyl and 5- to 6-membered heteroaryl included in the group G1 may be substituted with the same or different 1 to 3 substituents selected from a group GAr;
- the group GAr is a group consisting of —F, —Cl, hydroxy, cyano, C1-6 alkyl, halogeno-C1-6 alkyl, and —NH2;
- R11 is —H, C1-6 alkyl, halogeno-C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, halogeno-C1-6 alkoxy-C1-alkyl, or a 3- to 7-membered saturated ring group;
- R12 is C1-6 alkyl, halogeno-C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, halogeno-C1-6 alkoxy-C1-6 alkyl, a 3- to 7-membered saturated ring group, phenyl, or 5- or 6-membered heteroaryl, the phenyl and 5- or 6-membered heteroaryl as R12 may be substituted with the same or different 1 to 3 substituents selected from the group GAr;
- R2 is —H, C1-6 alkyl, halogeno-C1-6 alkyl, hydroxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, or a 3- to 7-membered saturated ring group;
- R3 is —H, C1-6 alkyl, halogeno-C1-6 alkyl, hydroxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, or a 3- to 7-membered saturated ring group;
- Ar is 6- to 10-membered aryl or 5- to 10-membered heteroaryl, Ar may be substituted with the same or different 1 to 3 substituents selected from the group G2;
- the group G2 is a group consisting of —F, —Cl, hydroxy, cyano, C1-6 alkyl, halogeno-C1-6 alkyl, hydroxy-C1-6 alkyl, RAr1—O—C1-3 alkyl, RAr1—NR13—C1-3 alkyl, —NR13C(O)R14, —C(O)NR13R14, —C(O)NH2, —NR13S(O2)R14, —S(O2) NR13R14, —NH2, —S(O2)NH2, —NR13R 14, and —NHC(O)NHR15;
- RAr1 is —H, C1-6 alkyl, halogeno-C1-6 alkyl, or a 3- to 7-membered saturated ring group, RAr1 may be substituted with the same or different 1 to 3 substituents selected from the group G3;
- the group G3 is a group consisting of —F, hydroxy, C1-3 alkyl, halogeno-C1-3 alkyl, oxo, C1-3 alkoxy, halogeno-C1-3 alkoxy, and a 3- to 7-membered saturated ring group;
- R13 is —H, C1-3 alkyl, halogeno-C1-3 alkyl, C1-3 alkoxy-C1-3 alkyl, halogeno-C1-3 alkoxy-C1-3 alkyl, or a 3- to 7-membered saturated ring group;
- R14 is C1-3 alkyl, halogeno-C1-3 alkyl, C1-3 alkoxy-C1-3 alkyl, halogeno-C1-3 alkoxy-C1-3 alkyl, or a 3- to 7-membered saturated ring group;
- R15 is —H, phenyl, or 5- or 6-membered heteroaryl, R15 may be substituted with the same or different 1 to 3 substituents selected from the group G4;
- the group G4 is a group consisting of halogen, cyano, C1-3 alkyl, and halogeno-C1-3 alkyl;
- X1 is N or CH;
- X2 is NH or O;
- X3 is a group represented by the following formula (1-1):
- the following formula (1-2):
- or
- the following formula (1-3):
- a and b represent direction of bonding:
- R21 and R22 are independently —H, C1-3 alkyl, or halogeno-C1-3 alkyl;
- X4 is a group represented by the following formula (2-1):
- b and c represent direction of bonding;
- in the formula (2-1),
- n is an integer of 1 to 3;
- Y is NR51 or O;
- R31 and R32 are independently —H, C1-3 alkyl, or halogeno-C1-3 alkyl;
- or
- R31 and R32 may combine to form a 3- to 6-membered saturated ring;
- R41 and R42 are independently —H, —F, hydroxy, C1-3 alkyl, halogeno-C1-3 alkyl, C1-3 alkoxy, or halogeno-C1-3 alkoxy;
- or
- R41 and R42 may combine to form a 3- to 6-membered saturated ring;
- R51 is —H, C1-3 alkyl, or halogeno-C1-3 alkyl;
- or
- R51 and R31 may combine to form a 4- to 6-membered saturated ring;
- X4 may be substituted with the same or different 1 to 3 substituents selected from the group G5;
- and
- the group G5 is a group consisting of —F, hydroxy, C1-3 alkyl, halogeno-C1-3 alkyl, C1-3 alkoxy, and halogeno-C1-3alkoxy,
- or a salt thereof.
A compound represented by the following formula:
- or a salt thereof.
A compound represented by the following formula:
- or a salt thereof.
A compound represented by the following formula:
- or a salt thereof.
A compound represented by the following formula:
- or a salt thereof.
A compound represented by the following formula:
- or a salt thereof.
A compound represented by the following formula:
- or a salt thereof.
A compound represented by the following formula:
- or a salt thereof.
Dependencies are inferred from the claim text.